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The  CBA/N  mouse  strain  has  a  well-characterized  syndrome of X-linked 
immunodeficiency (xid) 1 that principally affects B lymphocytes (1).  This strain 
has proved particularly useful in defining the two subsets of B  cells found in 
normal mice. Unlike CBA/N mice, normal mice contain a population of mature 
B cells that develops late in ontogeny, expresses Lyb 3,5 surface alloantigens and 
a  low density of IgM (reviewed in references  1-3).  Normal mice also contain 
immature B cells exhibiting a high density of surface IgM and a lack of Lyb 3,5 
alloantigens. These immature B cells are said to account for the vast majority of 
the B cells in CBA/N mice. 
Current concepts of the properties of the two B cell subsets rest heavily on the 
assumption that CBA/N B cells are indeed the counterpart of the immature B 
cells of normal mice. Although CBA/N B cells do share many of the features of 
normal  immature  B  cells,  it  is  equally conceivable  that  CBA/N  B  cells  are 
intrinsically abnormal and do not have an exact equivalent in normal mice. In 
support of this possibility, the present paper demonstrates that when irradiated 
mice are reconstituted with a  mixture of xid  and normal stem cells,  the xid  B 
cells differentiating in the chimeras eventually become totally replaced by B cells 
of the nondefective strain. By this parameter, xid B cells are a unique population 
not represented in normal mice. 
Materials and Methods 
Mice.  (C57B1/6 (B6) × CBA]J)F1, (AKR/J  ×  DBA/2)F,,  CBA/Ca,  BALB/c, and B6 
mice were obtained from The Jackson Laboratory, Bar Harbor, ME. CBA/N and (CBA/ 
N × DBA/2)F~ mice were kindly provided by Dr. D. Mosier, Institute for Cancer Research, 
Philadelphia, PA. Male mice were used unless stated otherwise. 
Preparation  of Chimeras.  Mice  were  irradiated and reconstituted with anti-Thy-l.2 
(monoclonal) and complement (C')-treated  marrow as described elsewhere (4). Chimeras 
were  maintained on  neomycin  and  polymyxin  B  in  the  drinking water  for  3-5  wk 
postreconstitution. 
Irradiation.  Mice  were exposed to ~37Cs ~-irradiation  using a Gamma cell irradiator 
(Atomic Energy of Canada) at a dose rate of 92 rads/min. 
This work was supported by U. S. Public Health Service grants AI 21687 and CA 38355. 
1  Abbreviations used in this paper:  C', complement; LN, lymph nodes; LPS, lipopolysaccharide; 
NMS, normal mouse serum; PFC, plaque-forming cells; TNP, trinitrophenyl;  xid, X-linked immu- 
nodeficiency. 
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Antibodies and Antisera.  The following antibodies were used: monoclonal anti-Thy-l.2 
(Jlj) antibody (5) (ascites  fluid diluted to  1:20); affinity-purified rabbit anti-mouse IgG 
(Rc~Mig) antiserum, diluted  1:10, obtained from Cappel Laboratories, Westchester, PA 
(see reference 6 for details on the specificity of this reagent); monoclonal antibody J1 ld 
(culture supernatant diluted 1:5), a reagent specific for >95% of B cells, most "null" cells 
and early hematopoietic cells  but not mature T  cells (5);  monoclonal anti-I-A  k (11-5.2) 
antibody (ascites fluid diluted 1:10) from hybridoma cells kindly provided by the Herzen- 
berg group, Stanford; monoclonal antibody BP107 specific for I-A  b'd but not  I-A  k (7) 
(ascites fluid diluted I : 10); monoclonal anti-KbD b (28-8-6s) antibody (culture supernatant 
diluted 1:5) (8); monoclonal anti-D  d (34-4-21 s) antibody (culture supernatant diluted 1:5) 
(8);  and  CBA/J  anti-B6  and  B6  anti-CBA/J  H-2  alioantisera  (9).  For detecting  H-2  b- 
bearing  cells,  CBA/J  anti-B6  antiserum  was  used  in  some  experiments  and  28-8-6s 
monocional antibody was used in others. 
Cytotoxicity Assays.  A one-step assay was employed, using Ficoll-gradient-separated cells 
(5). A mixture of mouse-spleen-absorbed guinea pig serum (final concentration 1:6) and 
rabbit serum  (final concentration  1:60) was  used as  a  source of C'.  Cell  viability was 
measured by phase contrast microscopy. 
Plaque-forming Cells (PFC) to Trinitrophenyl (TNP).  Direct anti-TNP PFC were assayed 
according to Rittenburg and Pratt (10). Anti-TNP PFC in the spleen were measured after 
intraperitoneal immunization of mice with 20 #g TNP54 aminoethylcarbamylmethyl Ficoll 
(TNP-Ficoll) or  20 ug TNP-lipopolysaccharide (TNP-LPS) kindly provided by Dr.  D. 
Mosier, Institute for Cancer Research, Philadelphia, PA. 
Identity of PFC.  The identity of PFC in the spleens of double chimeras was established 
according to the technique of Miller and Mitchell (9).  In brief, aliquots of spleen cells 
containing a known number of PFC were incubated in the presence of C' with anti-H-2 
antibody (either alloantisera or monoclonal antibody) or normal mouse serum (NMS). 
After this treatment the cells were then assayed for PFC in Cunningham chambers (9). 
Purification of T and B Cells.  B cell-enriched populations were prepared by treating 
spleen or lymph node (LN) cells (pooled cervical, inguinal, axillary, and mesenteric nodes) 
with anti-Thy-l.2 antibody plus C'. T  cell-enriched populations were obtained either by 
passing cells over nylon wool columns (5) or by treating the cells with a cocktail of  J1 ld 
and anti-I-A antibodies.  Dead ceils  were removed by Ficoli gradient separation before 
using the cells for cytotoxicity assays (5). 
Results 
Experimental Approach.  In addition  to B  cells,  the T  cells and  macrophages 
of CBA/N  mice are reported to show subtle abnormalities (1).  In  this respect, 
the initial aim of the experiments described below was to investigate whether the 
B cell defect in CBA/N mice was secondary to a defect in other cell types. If this 
were the case, the addition of normal (nondefective) lymphohematopoietic cells 
during early CBA/N B cell differentiation would be expected to abrogate the B 
cell defect. To investigate this question,  double ("tetraparental") bone marrow 
chimeras were prepared, using a mixture ofxid and normal stem cells. Irradiated 
(1,000  rads)  (BB  ×  CBA/J)F1  mice  were  reconstituted  with  a  mixture  of xid 
CBA/N  (H-2  k)  and  nondefective B6  (H-2  b)  T-depleted  marrow  cells  (CBA/N 
+  B6 --~ F1 chimeras) (Materials and Methods); controls were reconstituted with 
a  mixture of nondefective CBA/Ca  (H-2  k)  (closely related  to CBA/N) and  B6 
marrow cells (CBA/Ca +  B6 --~ F1 chimeras). The origin of the B cells differen- 
tiating in the chimeras was established with the aid of RaMig and specific anti- 
H-2 and anti-I-A reagents. 
Response of Double Chimeras to TNP-Ficoll and TNP-LPS: Origin of  PFC.  CBA/ 
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antigens, e.g. TNP-Ficoll, but react well to TI-1 antigens, e.g. TNP-LPS (1). To 
examine whether CBA/N B cells would gain responsiveness to TNP-Ficoll as the 
result  of differentiation  in  the  presence  of normal  lymphohematopoietic  cells, 
the above two groups of double chimeras were immunized with TNP-Ficoli at 6 
months postreconstitution. 
Both groups of chimeras gave high anti-TNP responses when splenic PFC were 
measured on day 6  (Table I).  To establish the identity of the PFC, aliquots of 
spleen cells pooled from each group were treated in the presence of C' with anti- 
H-2  k antibody, anti-H-2 b antibody,  or NMS, and  then assayed for numbers  of 
PFC. In the case of the CBA/Ca +  B6 ~  Fl chimeras,  PFC numbers relative to 
the  NMS controls were reduced by 75%  with anti-H-2 k antibody and  by  12% 
with anti-H-2 b antibody. This finding implied that although  the chimeras were 
reconstituted with equal numbers of CBA/Ca and B6 marrow cells, the majority 
of the PFC were of CBA/Ca origin.  [Possible reasons for this imbalance will be 
discussed later.] Very different findings were observed with the CBA/N +B6 ---, 
F~ chimeras.  In these chimeras, virtually all of the PFC were of B6 origin (Table 
I). Another experiment gave identical results. 
At face value,  the above data clearly implied  that  CBA/N-derived B cells in 
TABLE  I 
Identity of PFC in Spleens of CBA/N + B6 ~  F1 Double Bone Marrow Chimeras Immunized 6 
d Before with TNP-Ficoll 
Chimeras* 
No. of  Total numbers of di- 
mice/  rect (IgM) PFC/ 
group  spleen* 
No. of PFC after treating aliquots of 
spleen cells with anti-H-2 antibody + 
C,I 
No. of  % reduc- 
Antibody  PFC  tion 
CBA/Ca +  B6 ---, F~  3  128,622(1.11) 0  NMS  657  -- 
chimeras  a  H-2  b  576  12 
a  H-2 k  164  75 
CBA/N +  B6 ~  F~  3  80,910(1.11)  NMS  675  -- 
chimeras  a  H-2 b  13  98 
a  H-2 k  682  0 
Normal B6  1  183,620 
Normal CBA/J  1  34,000 
NMS  351  -- 
a  H-2  b  36  90 
a  H-2 k  297  15 
NMS  522  -- 
a  H-2 b  540  0 
a  H-2 k  13  98 
* (B6 x  CBA/J)FI mice were exposed to 1,000 rads and injected with a  1:1  mixture (2 x  106 of each) 
of anti-Thy-l.2 +  C'-treated marrow cells taken from B6 and CBA/Ca or CBA/N mice. Chimeras 
were tested at 6  months post-reconstitution. 
* Mice immunized with 20 #g TNP-Ficoll given intraperitoneally.  Normal CBA/N mice, not tested 
in this particular experiment, were invariably totally unresponsive to TNP-FicolI. 
Geometric mean; number in parentheses is the value by which the mean is multiplied or divided to 
give upper and lower limits of the SE. 
! See  Materials and Methods for details.  Pooled  spleen cells from each group were  used for  PFC 
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the chimeras remained totally unresponsive to TNP-Ficoil. Nevertheless, it was 
important  to  show  that  CBA/N-derived  B  cells  were  indeed  present  in  the 
chimeras. The chimeras were therefore immunized against TNP-LPS, a  known 
immunogen for CBA/N B cells (see above). Surprisingly, virtually all of the anti- 
TNP PFC in the CBA/N +  B6 ~  F1 chimeras given TNP-LPS were of B6 origin, 
i.e., 100% of the PFC were killed with anti-H-2  b antibody plus C' (Table II); this 
treatment  lysed  only  ~30%  of  PFC  in  spleens  of the  CBA/Ca  +  B6  ---* F~ 
chimeras,  implying  that  most  of the  PFC  in  these  chimeras  were  of CBA/Ca 
origin.  In  a  further  experiment,  the  two  groups  of  double  chimeras  were 
immunized  against  horse  erythrocytes (HRC),  a  T-dependent  antigen.  As  for 
responses to TNP-Ficoll and TNP-LPS, virtually all of the anti-HRC PFC in the 
CBA/N  +  B6 ~  F~ chimeras were of B6 origin (compared with <30%  B6 PFC 
in CBA/Ca +  B6 ~  Fl chimeras) (data not shown). 
Two possibilities could account for the above findings: (a) The CBA/N-derived 
B  cells  in  the  chimeras  were  unresponsive  to all  three antigens  tested,  or  (b) 
CBA/N-derived  B  cells  failed  to  differentiate in  the  chimeras.  To  assess  this 
second possibility, the identity of total T  and B lymphocytes in the chimeras was 
tested. 
Identity  of T  and  B  Cells in  Double  Chimeras.  Spleen and  LN  cells from the 
two groups of double chimeras were passed over nylon wool columns or treated 
with  anti-Thy-1  antibody  and  C'  to  yield  populations  enriched  for  T  or  B 
lymphocytes,  respectively.  The  identity  of the  T  and  B  cells  was  assessed  by 
cytotoxicity, using anti-H-2 and anti-I-A antibodies (Table III). In the case of the 
CBA/Ca +  B6 ~  F] chimeras, approximately two-thirds of the B (Thy-l-, I-A  +) 
cells were of CBA/Ca origin and one-third of B6 origin. These data correlated 
closely with  the origin  of the antigen-specific PFC  in  these chimeras (Tables I 
and  II).  B  cells in  the  CBA/N  +  B6 --* F]  chimeras,  by contrast,  were almost 
entirely of B6 origin. The proportion of CBA/N-derived B cells was very small 
TABLE  II 
Identity of PFC in Spleens of CBA/N + B6 ~  Fl Double Bone Marrow Chimeras Immunized 5 
d Before with TNP-LPS 
No. of  Total no. of direct 
Chimeras*  mice/  (IgM)  PFC/spleen* 
group 
No. of PFC after treating aliquots of 
spleen cells with anti-H-2 antibody 
+  C '1 
No. of  % reduc- 
Antibody  PFC  tion 
CBA/Ca + B6 ~  FI  5  58,940(1.18)  0  --  620  -- 
chimeras  a H-2  b  440  29 
CBA/N + B6 ---, FI  4  20,290(1.21)  --  490  -- 
chimeras  a H-2  b  0  100 
Normal (B6 × CBA/J)F]  1  84,600  --  212  -- 
ot H-2  b  3  99 
* As for Table I. 
* Mice were immunized with 20 #g TNP-LPS given intraperitoneally. 
~! As for Table I. SPRENT  AND  BRUCE  715 
TABLE  III 
Paucity of CBA/N B Cells but Not T Cells in CBA/N + B6 ~  F~ Double Bone Marrow 
Chimeras 
Time after 
Chimeras tested*  marrow  Cells tested* 
reconstitution 
Cytotoxic indices witht: 
aThy- RaMig aI-A  k  aI-A  b  all-2  k all-2  b 
1.2 
CBA/Ca ---* Fl  6 months  Unsep. spleen  25  43  48  0  97  2 
CBA/N ~  F1  6 months  Unsep. spleen  28  38  31  0  96  1 
CBA/Ca + B6 ~  Ft  6 months  Spleen B  6  76  64  35  70  34 
LN  B  5  99  --  --  68  44 
LN  T  91  2  --  --  55  58 
CBA/N + B6 ~  Fl  6 months  Spleen B  2  77  7  82  8  91 
LN  B  2  96  --  --  9  97 
LN  T  90  7  --  --  54  54 
CBA/Ca + B6 ---* F1  9 months  Spleen B  0  65  60  26  57  29 
LN  T  96  0  0  2  70  43 
CBA/N + B6 ~  Fl  9 months  Spleen B  0  74  2  88  0  88 
LN  T  95  0  0  0  72  42 
* As for Table I. 
* Spleen or LN B, cells pretreated with anti-Thy-l.2 antibody + C'; LN T, nylon wool-purified LN 
cells or LN cells pretreated with J 1 ld (anti-B) antibody plus C' (see Materials and Methods). 
In the case of unseparated (Unsep.) spleen cells or spleen B cells, cell suspensions from individual 
mice (3 mice/group) were tested. For these cells the data shown in the table represent the arithmetic 
mean of the values obtained. For convenience SD are not shown;  SD were generally within 10- 
20% of the mean. In the case of LN B cells and LN T cells, cells from 3 mice/group were pooled 
to prepare the purified cells. Cytotoxic indices were then established on the pooled cells. 
("8%).  Indeed,  when  further  chimeras of the same batch were left for another 
3  months  (9  months  post-reconstitution),  virtually no  CBA/N-derived  B  cells 
were detected  (Table  III).  It should be mentioned  that  CBA/N-derived  B  cells 
were  readily detected  in  single chimeras,  i.e.,  irradiated  (B6  x  CBA/J)F1  mice 
reconstituted with CBA/N  marrow  alone (Table III). 
In  marked  contrast  to  B  cells,  a  high  proportion  (~50%)  of the  T  cells  in 
CBA/N  +  B6 ---* Fx chimeras were of CBA/N  (H-2 k) origin. Indeed, the ratio of 
CBA:B6 T  cells was indistinguishable in the two groups of double chimeras. 
[Note that  the sum of the cytotoxic indices observed with anti-H-2  k and anti- 
H-2 b antibodies  sometimes  exceeded  100%,  particularly in  the  case  of LN  T 
cells. Such a  finding indicates that a  small proportion  of the cells were of F~ host 
origin. On  this point, previous studies have shown  that although  very few stem 
cells or B  cells withstand heavy irradiation (1,000  rads), small numbers  of T  cells 
can survive for several months  post-irradiation (6).] 
Time Course of Survival of CBA/N-derived B Cells in Double Chimeras.  Since the 
double  chimeras  in  the  above  experiments  were  typed  at  ~6  months  post- 
reconstitution,  it  was  important  to  determine  whether  CBA/N-derived  B  cells 
were  detectable at an  earlier stage  post-reconstitution.  To  study this  question, 
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were prepared.  The chimeras were then  typed for the origin of their lymphoid 
cells at 1.5, 3.5, 7.5, and 20 wk post-reconstitution. The data shown in Table IV 
can be summarized as follows. 
At  1.5 wk post-reconstitution,  the spleens of both types of chimeras consisted 
largely of Ig-I-A-  "null"  cells,  the  vast majority of which  were of CBA origin 
(see below). 
At 3.5 wk, Thy-1 ÷, Ig  +, and I-A  + cells were detectable in the spleen, but only 
in small numbers. Typing with anti-I-A antibodies indicated that I-A  k cells were 
more common than  I-A  b cells in both groups of chimeras. 
At 7.5 wk, typical T  and B cells were conspicuous in both spleen and LN.  In 
the case of the CBA/Ca +  B6 ~  F1 chimeras, B (Thy-l-, I-A  +) cells were derived 
from both parental strains, with only a slight preponderance of CBA/Ca-derived 
cells (compare with the origin of the null cells at  1.5 wk). In the CBA/N +  B6 
F1 chimeras, B6-derived B cells clearly predominated.  Significantly, however, 
in  contrast  to  the  long-term  reconstituted  chimeras  considered  earlier  (Table 
III), CBA/N-derived B cells were present in appreciable numbers, both in spleen 
and LN (---20%). The T  cells in both groups of chimeras were predominantly of 
CBA origin (=2:1  ratio of CBA:B6). 
By  20  wk  post-reconstitution,  the  proportion  of CBA/N-derived  B  cells  in 
TABLE  IV 
Appearance,  Then Disappearance of CBA/N-derived B Cells in CBA/N + B6 ~  Fi Double 
Chimeras: Time Course 
Time after 
Chimeras tested*  marrow  Cells tested* 
reconsti- 
tution 
Cytotoxic indices withf: 
aThy- ~  •  .  1.2  Kotlvllg al-A  k  al-A  b  Jlld  all-2 k all-2 b 
CBA/Ca +  B6---~FI 
chimeras 
1.5 wk  Unsep. spleen 
3.5 wk  Unsep. spleen 
7.5 wk  Spleen  B 
LN  B 
LN  T 
20 wk  Spleen  B 
LN  B 
LN  T 
2  3  5  6  59  71  9 
10  16  21  14  78  65  38 
4  87  61  37  93  64  42 
0  93  70  47  90  68  46 
88  7  0  0  0  83  36 
0  --  50  50  --  51  54 
0  91  46  56  --  42  62 
94  0  0  0  --  86  41 
CBA/N+  B6--~FI 
chimeras 
1.5  wk  Unsep. spleen 
3.5 wk  Unsep. spleen 
7.5 wk  Spleen  B 
LN  B 
LN  T 
20 wk  Spleen  B 
LN  B 
LN  T 
1  3  3  4  50  62  9 
11  10  8  3  71  64  32 
2  63  18  64  84  32  64 
0  96  20  87  91  29  78 
91  7  3  3  0  75  39 
1  --  4  86  --  13  79 
1  88  4  87  --  6  87 
96  2  1  6  --  90  17 
CBA/Ca ~  FI 
chimeras 
20 wk  Unsep. spleen  24  62  78  2  --  --  5 
CBA/N--~Fz 
chimeras 
20 wk  Unsep. spleen  49  31  49  0  --  --  2 
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CBA/N  +  B6 ~  F1  chimeras  had  fallen  to very low levels (<5%  I-Ak+). The 
proportion  of CBA/N-derived  T  cells in  these chimeras,  by contrast,  was very 
high,  in  fact  higher  than  at  7.5  wk.  In  the  case of the  CBA/Ca  +  B6 ~  F~ 
chimeras,  the origin of the T  and B cells at 20 wk was similar to 7.5 wk except 
for a relative increase in B6-derived B cells. 
The  significant  finding in  the above experiment  was that  CBA/N-derived B 
cells did  make  an  appearance  in  CBA/N  +  B6 ~  F~  chimeras,  but  that  this 
appearance  was  only  transient.  It  should  be  mentioned  that  results  virtually 
identical to those shown in Table IV were obtained in an additional experiment 
with a quite separate batch of chimeras (data not shown). 
Before proceeding,  comment  should  be on  the  conspicuous  paucity of B6- 
derived null  cells in  the double chimeras assayed at  1.5  wk post-reconstitution 
(Table IV). In all probability, this was a  manifestation of Hh resistance, B6 (D  b) 
cells being particularly susceptible to this reaction (11). To seek support for this 
explanation,  a  50:50 mixture of CBA/N and B6 marrow cells (2 ×  106 of each) 
were transferred  to Ft mice conditioned by split dose irradiation,  i.e., 600 rads 
followed  2  wk  later  by  1,000  rads.  This  procedure  is  known  to  abolish  Hh 
resistance (11).  When spleens from the chimeras were removed  1 wk later,  the 
ratio of B6:CBA cells was now close to 1:1 (data not shown). This compared with 
a  ratio  of about  1:15  when  control  mice received a  single dose of 1,000 rads. 
Although these data strongly suggest that Hh resistance was responsible for the 
early paucity of B6-derived cells in the spleen, it might be asked why these cells 
rebounded in proportion at later stages (see Table IV). The likely answer is that 
the effector cells for Hh resistance are short-lived cells that reside largely in the 
spleen, but not in other organs (11). Donor B6 marrow cells seeding the marrow 
cavity of the recipients fail to encounter Hh resistance: the descendants of these 
cells then appear in the spleen once Hh resistance in this organ has waned. 
The irradiated  hosts in the preceeding experiments were all (B6 ×  CBA/J)F~ 
mice.  To determine  whether  CBA/N-derived  B  cells would fail  to thrive  in  a 
different F1 combination,  (AKR X DBA/2)F1 (H-2  k X H-2  a) mice were used as 
recipients of a mixture of BALB/c (H-2  d) and CBA/N or CBA/Ca (H-2  k) marrow. 
As  shown  in  Table  V,  control  single  chimeras  prepared  by  injecting  either 
CBA/Ca or CBA/N marrow cells alone were near totally repopulated with donor- 
derived T  and B cells when the chimeras were typed 4 months later. The splenic 
B cells from CBA/Ca +  BALB/c ~  F~ chimeras were derived from both parental 
strains with an unexpected preponderance of BALB/c (I-Aa)-derived cells. ~20% 
of the B cells were CBA/Ca (I-Ak)-derived. In CBA/N +  BALB/c ~  F~ chimeras, 
by  contrast,  CBA/N  (I-Ak)-derived  B  cells  were  completely  undetectable. 
CBA/N-derived T  cells,  however, were conspicuous and  indeed outnumbered 
the BALB/c-derived T  cells. 
Double Chimeras Prepared  with Sublethal  Irradiation.  A  dose of irradiation  in 
the range  of 750  rads destroys the vast majority of mature  T  and  B cells, but 
spares small numbers of CFU/s. Transfer of parental strain marrow cells to these 
mice thus produces a form of double chimera in which the lymphohematopoietic 
system is derived from both donor and host (12). Table VI shows the effects of 
transferring CBA/Ca vs. CBA/N marrow cells to sublethally irradiated (CBA/N 
×  DBA/2)FI  mice; the recipients were either female (normal,  nondefective) or 718  DISAPPEARANCE  OF  xid  B  CELLS  IN  DOUBLE  CHIMERAS 
TABLW V 
Paucity of CBA/N-derived B Cells but Not T Cells in Irradiated (AKR/J × DBA/2)F1 Mice 
Reconstituted with CBA/N Plus BALB/C Marrow Cells 4 Months Previously 
Chimeras tested* 
Cells tested*  No. of  Cytotoxic indices withl: 
Mice  aThy-1.2  RaMig  al-A  a  al-A  k  all-2  d  all.2 k 
CBA/Ca +  BALB/c  Spleen  B  6  0  63(=1=4)  65(:t:3)  21(:t:2)  -- 
Fi chimeras  LN  T  97  0  3  4  66 
CBA/N +  BALB/c  Spleen  B  8  0  62(±2)  92(±4)  0  -- 
-* Fi chimeras  LN  T  96  4  0  0  44 
CBA/Ca --* Fi  Unsep. spleen  3  24(±6)  58(±1)  4(±4)  75(±4)  4(±4) 
chimeras 
CBA/N --* Fl  Unsep. spleen  3  53(±6)  31(±10)  4(±3)  46(±7)  4(±4) 
chimeras 
45 
64 
* Fz mice were exposed to 1,000 rads and then, 4  h  later, injected intravenously with anti-Thy-l-treated marrow cells in a dose of 2 
x  10  s cells (2 x  10  s of each population for double chimeras). 
*0 As for Table 111; SD are shown in parentheses (except for LN T  where pooled cells were used--see Table llI). 
TABLE  VI 
Identity ofT and B Cells in Sublethally Irradiated (750 rads) (CBA/N × DBA/2)F~ Female 
vs. Male Mice Reconstituted  with CBA/Ca vs. CBA/N Marrow Cells 
Cytotoxic indices withl: 
Immune status of  Cells 
Group  Chimeras*  donor/recipient  examined*  c~Thy-  RaMig  aH'2d 
1.2  (anti-host) 
1  CBA/Ca ~  FI 9  Normal --~ normal  Spleen  B  0  78(+4)  34(-+2) 
LN  T  96  0  20 
2  CBA/N ~  F~ d  xid ~  xid  Spleen  B  0  64(+7)  25(_+2) 
LN  T  99  0  50 
3  CBA/Ca ~  F~ d  Normal ~  xid  Spleen  B  0  78(___4)  1  (+ 1 ) 
LN  T  98  0  25 
4  CBA/N ~  Fl 9  xid ---* normal  Spleen  B  0  68(+10)  74(+7) 
LN  T  97  0  29 
* F~ mice were exposed to 750 rads and then injected intravenously with 2 ×  106 T  cell-depleted 
CBA/Ca or CBA/N male marrow cells. Chimeras were assayed at 4  months post-reconstitution. 
*! As for Tables III, V. 
male (xid). T  and B cells were typed at 4 months post-reconstitution. The results 
can be summarized as follows. 
In the case of B cells, the proportion of host (H-2d-bearing) cells in CBA/Ca 
Fl  ~ chimeras (Group  1) and CBA/N  ~  F1 ~  chimeras (Group  2) was quite 
similar (34% vs. 25%). Note that in these two situations, the donor and host were 
either both  nondefective (normal)  (Group  1)  or both  defective (xid)  (Group  2). 
Very different results  were seen  in  the  other  two situations.  With  transfer  of 
nondefective  marrow  to xid  recipients  (CBA/Ca  ---* F~  c~,  Group  3),  host  cells 
were virtually undetectable (1%).  In marked contrast, host cells reached 74% in 
the reciprocal situation, i.e., with transfer of xid marrow to nondefective recipi- SPRENT  AND  BRUCE  719 
ents (CBA/N ---* F1  9,  Group  4).  In the case of T  cells, there was no marked 
variation in the proportion of host cells among the four groups (20-50%). 
These results indicate that normal B cells displace xid B cells, irrespective of 
whether the xid B cells originate from the donor marrow or from the FI  host. 
These  data  with  sublethally  irradiated  chimeras thus  corroborate  the  earlier 
findings with xid B cell growth in double chimeras given lethal irradiation (Tables 
III-V). 
Pluripotential Stem Cells in Long-term CBA/N + B6 ~  Fl Double Chimeras.  The 
finding that CBA/N-marrow-derived B cells were virtually absent in long-term 
reconstituted double chimeras given  1,000 rads (Table III) raised the question 
of whether CBA/N-derived CFU/s would survive in these chimeras. To examine 
this question, marrow cells were taken from CBA/N +  B6 ~  (B6  x  CBA/J)FI 
chimeras at 5 months post-reconstitution; the spleens of these chimeras contained 
~:5% I-Ak-bearing cells. As controls, marrow cells were also taken from CBA/Ca 
+  B6 ~  F1 chimeras; these chimeras contained >60%  I-Ak-bearing cells in the 
spleen. Marrow cells (4 x  106 anti-Thy-l-treated cells) from these two groups of 
chimeras (3  donors/group) were transferred to normal (B6  X CBA/J)Fl  mice, 
pretreated with split dose irradiation (600 rads plus 1,000 rads) to overcome Hh 
resistance. Spleens were removed from the recipients 7 d  later and typed with 
anti-H-2 antibody; the spleens at this stage were large (~ 10 s cells) and consisted 
mostly of primitive hematopoietic cells. As shown in Table VII, the proportion 
of B6-derived cells, i.e., cells lysed by anti-H-2  b antibody, was very similar in the 
two groups  (---40%).  As controls,  the anti-H-2  b antibody lysed <2%  of spleen 
cells from irradiated FI  mice given normal (nonchimeric) CBA/N marrow 7 d 
TABLE  VII 
Survival of CBA/N-Derived Pluripotential Stem Cells in Long-term Double Chimeras: Identity 
of Spleen Cells in Lethally Irradiated (B6 x  CBA/J)F~ Mice Injected 7 d Before with Marrow 
Cells  from CBA/N + B6 ---* Fl Chimeras 
Identity of spleen 
Recipients of marrow  Total no. of cells/  cells removed at 7 
Donors of mar-  cells pretreated with split-  spleen (x  10  -8)  days: cytotoxic in. 
row cells*  dose irradiation  s  dices with anti-H- 
2 b +  C' 
CBA/Ca +  B6 ~  Fa  (B6 x  CBA/J)F~  98(__. 12)  36(__. 12)  0 
chimeras 
CBA/N +  B6 ----, F,  (B6 x  CBA/J)F~  130(+22)  38(+3) 
chimeras 
Normal CBA/N  (B6 x  CBA/J)F~  115(_.+5)  1(__.3) 
Normal B6  (B6 ×  CBA/J)F~  105(---25)  84(+8) 
* Marrow cells were taken from the chimeras at 6  months post-reconstitution; the chimeras were 
from the same batch used in Table IV. Marrow cells pooled from 3 chimeras/group were treated 
with anti-Thy-1  antibody +  C' and transferred intravenously in a  dose of 4  X  10  6 viable cells/ 
mouse. 
* Mice were first exposed to 600 rads, left for  10 d  and then exposed to  1,000 rads; marrow cells 
were transferred 4 h after the second dose of irradiation. 
Arithmetic mean of 3 mice/group (+ SD). 720  DISAPPEARANCE  OF  xid  B  CELLS  IN  DOUBLE  CHIMERAS 
before, and  84%  of spleen  cells from  F1  mice given  normal  B6 marrow  cells. 
These data imply that the early hematopoietic cells developing in the spleens of 
both  groups  of irradiated  mice  given  chimera  marrow  cells  were  derived  in 
approximately  equal  proportions  from  CBA  and  B6  stem  cells  in  the  donor 
marrow.  In contrast to B cells, there was thus no evidence that CBA/N-derived 
CFU/s become outnumbered  by normal  CFU/s during  long-term  residence in 
the chimeras. 
Discussion 
The results in this paper demonstrate that xid B cells differentiating from stem 
cells in  bone marrow  chimeras  gradually  disappear  when  the  chimeras  harbor 
stem cells/B cells from nondefective mice. xid  B cells are detectable within  the 
first  1-2 months of marrow reconstitution,  but then  eventually become almost 
totally replaced by normal  B cells, both in spleen and  LN. This replacement of 
xid cells by normal cells does not apply to T  cells or CFU/s. 
On a priori grounds, one might argue that the gradual disappearance of xid B 
cells in chimeras is a reflection of chronic alloaggression, mediated either by the 
irradiated  host or by cells differentiating from the nondefective marrow inocu- 
lure. Rejection by the host would seem to be ruled out by the finding that xid B 
cells differentiate effectively in CBA/N -o F1 single chimeras (mice reconstituted 
with CBA/N marrow alone, Tables III and V). Alloaggression mediated by cells 
derived from the nondefective marrow also seems most unlikely. To sustain this 
argument  one would have to postulate a  novel form of ailoaggression  that  (a) 
escapes tolerance induction (the marrow cells were rigorously T-depleted before 
transfer),  (b) is  unidirectional  (anti-xid  but  not  vice versa),  and  (c)  is  directed 
selectively to xid B cells and not other xid-marrow-derived  cells, i.e., T  cells or 
CFU/s. Perhaps the most convincing evidence against alloaggression is provided 
by the data on the growth of xid B cells in sublethaily irradiated  CBA/N (male) 
---* (CBA/N ×  DBA/2)FI male vs. female mice (Table VI). Here it was found that 
CBA/N-derived B cells differentiated well in the male Fl recipients (xid ~  xid) 
but  not  in  the  female  recipients  (xid --o  normal).  Interpreting  this  finding  in 
terms of alloaggression  is virtually impossible.  [A response to a  Y-chromosome 
controlled antigen  is ruled out by the fact that  CBA/Ca male B cells grew well 
in F1 female recipients.] 
If alloaggression can be disregarded,  the simplest interpretation  of the data is 
that the rate of differentiation of xid B cells is slightly slower than  for normal  B 
cells. A precedent for this notion stems from findings of Kincade et al. (13). This 
group has reported  that,  unlike normal  B cells, xid  B cells are  unable to form 
colonies in agar.  These workers observed that young heterozygous female mice 
raised between xid  and  normal  mice  contained  about one-half the  number  of 
colony-forming B cells as homozygous normal mice, implying that the heterozy- 
gotes are X-chromosome mosaics containing a roughly 1  : 1 ratio of defective and 
normal  B  cells.  Interestingly,  the  reduction  in  colony-forming B  cells was less 
apparent  in  older  heterozygotes,  suggesting  that  the xid  B  cells in  these  mice 
gradually become replaced by normal  B cells.  More recently, Nahm  et al.  (14) 
used X-chromosome linked alloenzymes to study mosaicism in xid-heterozygous 
females.  These  workers observed that,  in  marked  contrast  to other cell  types, SPRENT  AND  BRUCE  721 
spleen cells enriched for B cells were "nearly devoid" of the isoenzyme encoded 
by the X-chromosome bearing the xid gene. This suggested a virtual absence of 
xid B cells in the heterozygotes. Unfortunately, the age of the mice examined in 
this elegant study was not stated. If old mice were used, the data would be fully 
consistent with the data of Kincade et al. (13) mentioned above and also with the 
findings in the present paper. 
Although the life history of B  cells is  still  not  fully understood,  in  mice it 
appears to involve production in the marrow (15), selection and differentiation 
in  the  spleen  (16,  17),  followed by  entry of a  portion  of the  cells  into  the 
recirculating lymphocyte pool (18).  Some B ceils are presumed to die rapidly, 
whereas others survive for many months in interphase. Precisely where in this 
life history normal B cells have a growth/survival advantage over xid B cells is 
unclear. The finding that xid  B  cells do appear  within the first few weeks of 
reconstitution and then disappear progressively suggests that a reduced rate of 
production ofxid B cells in the marrow is probably not the explanation.  2 Likewise, 
the kinetics of the appearance and disappearance of xid  B  cells is against the 
possibility  that xid  B  cells die  more rapidly than  normal  B  cells (see below). 
Although neither of these possibilities can be ruled out, we lean to the view that 
xid B cells might have a reduced capacity to turn over (expand) in the secondary 
lymphoid tissues,  perhaps  in  response  to environmental antigens or mitogens 
(see reference 13).  In this respect, it is well documented that xid B cells respond 
poorly in vitro to certain antigens and mitogens, including anti-Ig and particular 
extracts of LPS  (1,  19).  Recent studies from this  laboratory have shown that 
most xid B cells do turn over (incorporate tritiated thymidine) at a slow rate in 
vivo. s Whether the rate of turnover of xid B cells is actually slower than normal 
B cells, however, is not clear from the available data. 
The finding that xid B cells tend to disappear in the presence of normal B cells 
adds to the accumulating evidence that xid B cells probably cannot be equated 
with the Lyb 5- subset of immature B cells found in normal mice (see below, and 
reference  19).  In  our  view,  xid  B  cells  are  a  unique  population  that  is  not 
represented in normal mice. xid B cells certainly resemble normal Lyb 5- B cells 
in  several respects,  notably in  the capacity to  respond only to  TI-1  and  not 
T1-2  antigens  (1).  In  other respects,  however, xid  B  cells share some of the 
properties attributed to mature Lyb 5 + B cells, e.g. a slow turnover (for LN and 
most splenic B cells),  3 capacity to recirculate  3 and the expression of strong Mls 
determinants (20).  The retarded differentiation of xid B cells (this paper) and 
the odd  T-dependency of xid  B  cell differentiation (6,  21,  22),  however, sets 
these cells apart from both the Lyb 5- and Lyb 5 + B subsets of normal mice. 
Although it  is  difficult to provide a  simple explanation for how the xid  gene 
might control these various departures from normal B cell physiology, a subtle 
2 Assuming that xid mice have ~30% of the number of total B cells found in normal mice (reference 
1), double chimeras constructed with a  1:1 mixture of xid and normal B cells would be expected to 
generate xid and normal B cells in a  ratio of 1:3-4.  In this respect it is of interest that early after 
k  b  marrow reconstitution, i.e., at 7 wk, the ratio of CBA:B6 (I-A :I-A ) B cells in the spleen was  1:3.6 
in CBA/N +  B6 ~  Fl chimeras vs.  1.6:1  in CBA/Ca +  B6 ---* Fi chimeras (calculated from the data 
in Table IV). Comparison of these two ratios gives a relative ratio of 1:6, quite close to the ratio of 
1:3-4 considered above. 
3 Sprent, J., and J. Bruce.  1984. Physiology of B cells in mice with X-linked immunodeficiency. I. 
Size, migratory properties and turnover of the B cell pool. Manuscript in preparation. 722  DISAPPEARANCE OF xid  B CELLS IN  DOUBLE CHIMERAS 
alteration in the biochemistry of xid cells is a logical working hypothesis. Search- 
ing for such alterations might be informative. 
Summary 
Evidence is presented that B cells from mice with X-linked immunodeficiency 
(xid) differentiate at a  slower rate than normal B cells.  This conclusion stems 
from studies in which (B6  x  CBA/J)F1 mice were heavily irradiated (1,000 rads) 
and reconstituted with a  mixture of T-depleted marrow  cells  taken from (a) 
nondefective B6 mice (H-2  b) and (b) xid CBA/N or nondefective CBA/Ca mice 
(both  H-2k).  With  transfer  of CBA/Ca plus  B6  marrow  cells,  the  irradiated 
recipients become repopulated with B cells derived from both parental marrow 
sources; except for an early imbalance (probably reflecting Hh resistance), the 
degree  of chimerism  remained relatively stable  over  a  period  of more  than 
6  months.  Very  different results  occurred  with  transfer  of a  mixture of xid 
CBA/N  and  normal  B6  marrow.  Within  the  first  2  months  after  marrow 
reconstitution, a low but significant proportion of the B cells in both spleen and 
lymph nodes were of CBA/N origin. Thereafter the proportion of these cells fell 
progressively, and by 6-9 months virtually all of the B cells were of B6 origin. 
This gradual decline in CBA/N-derived cells  did not apply to other cell types, 
i.e., T  cells  or pluripotential stem cells.  Analogous results were obtained with 
transfer of CBA/N  vs.  CBA/Ca marrow cells into sublethally irradiated (750 
rads) (CBA/N x  DBA/2)F1 male vs. female mice. For example, CBA/N-marrow 
derived B cells differentiated effectively and survived for long periods in F1 male 
mice (xid ~  xid) but not in Fl female mice (xid ~  normal). 
The finding that xid B cells eventually disappear in the presence of normal B 
cells  strengthens  the  view  that  xid  B  cells  are  an  abnormal  population  not 
represented in normal mice. 
Received  for publication 7 May 1984. 
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